Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-130490
Filing Date
2026-03-30
Accepted
2026-03-30 08:35:41
Documents
89
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tpst-20251231.htm   iXBRL 10-K 3017171
2 EX-4.1 tpst-ex4_1.htm EX-4.1 84125
3 EX-10.12 tpst-ex10_12.htm EX-10.12 11343
4 EX-10.25 tpst-ex10_25.htm EX-10.25 340201
5 EX-10.26 tpst-ex10_26.htm EX-10.26 361563
6 EX-10.27 tpst-ex10_27.htm EX-10.27 133310
7 EX-10.28 tpst-ex10_28.htm EX-10.28 89715
8 EX-10.29 tpst-ex10_29.htm EX-10.29 85449
9 EX-23.1 tpst-ex23_1.htm EX-23.1 13074
10 EX-31.1 tpst-ex31_1.htm EX-31.1 20679
11 EX-31.2 tpst-ex31_2.htm EX-31.2 21859
12 EX-32.1 tpst-ex32_1.htm EX-32.1 11240
13 GRAPHIC img81402019_0.jpg GRAPHIC 50973
14 GRAPHIC img81402019_1.jpg GRAPHIC 31431
15 GRAPHIC img81402019_2.jpg GRAPHIC 223246
16 GRAPHIC img81402019_3.jpg GRAPHIC 216537
17 GRAPHIC img81402019_4.jpg GRAPHIC 104315
18 GRAPHIC img81402019_5.jpg GRAPHIC 67150
19 GRAPHIC img81402019_6.jpg GRAPHIC 97868
20 GRAPHIC img81402019_7.jpg GRAPHIC 237726
21 GRAPHIC img81402019_8.jpg GRAPHIC 313680
22 GRAPHIC img81402019_9.jpg GRAPHIC 154000
  Complete submission text file 0001193125-26-130490.txt   15007977

Data Files

Seq Description Document Type Size
23 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tpst-20251231.xsd EX-101.SCH 1259813
93 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20251231_htm.xml XML 1412132
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35890 | Film No.: 26810105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)